260
K. Lukin and V. Kishore
Vol 51
General procedure for the synthesis of acylamidoximes
acylamidoximes in the presence of DBU. Under these new
conditions, many previously challenging compounds could
be obtained in high yields. As an added convenience, the
method eliminates a necessity to conduct the reactions at
high temperatures, in microwave ovens, or in the presence
of molecular sieves. In a typical example, the overall time
required for the preparation and isolation of oxadiazole
products is reduced to 1.5–2 h.
7a–e.
Carboxylic acid 4a,b, 5 (1.05 mmol) is added to a
solution of CDI (0.17 g, 1.05 mmol) in acetonitrile (3.0 mL).
Upon the completion of carbon dioxide evolution, amidoxime 6
(1.0 mmol) is added to the reaction mixture and the agitation is
continued for 30 min at RT. The mixture is then diluted with
water (3.0 mL), and the product is filtered, washed with 1:1
ACN-water (1.5 mL) and dried under vacuum at 40 ꢀC to give
compounds 7a–e.
4-Fluoro-N’-(4-nitrobenzoyloxy)benzimidamide (7c). was
isolated in 89% yield; 1H nmr (d, DMSO-d6): 7.14 (broad
s, 2H), 7.32 (m, 2H), 7.82 (m, 2H), 8.32 (d, 2H), 8.42 (d, 2H);
13C NMR (d, DMSO-d6): 115.0 (d, 2C), 123.1 (2C), 127.4,
128.8 (d, 2C), 130.5 (2C), 134.1, 149.5, 156.0, 161.5. 162.8 (d).
Anal. Calcd. For C14H10FN3O4: C, 55.45; H, 3.32; N, 13.86.
Found: C, 55.25; H, 3.10; N, 14.13.
EXPERIMENTAL
General.
The reactions were monitored by HPLC method
utilizing Zorbax Eclipse XDB-C18 (Agilent Technologies)
column with detection at 205 nm. Reaction yields were
determined by HPLC method using standard solutions of the
corresponding isolated purified compounds as a reference.
General procedure for one-pot preparation of oxadiazoles 1,
4-Fluoro-N’-(2-phenylacetoxy)benzimidamide (5). was
1
isolated in 90% yield. H NMR (d, DMSO-d6): 3.81 (s, 2H), 6.89
(broad s, 2H), 7.21–7.31 (m, 3H), 7.31–7.36 (m, 4H), 7.75 (m, 2H).
13C NMR (d, DMSO-d6): 39.3; 114.8 (d, 2C), 126.3, 127.4, 127.8
(2C), 128.6 (d, 2C), 128.9 (2C), 134.1, 155.4, 162.7 (d), 168.2. Anal.
Calcd. For C15H13FN2O2: C, 66.17; H, 4.81; N, 10.29. Found: C,
66.05; H, 4.85; N, 10.33.
Previously reported in the literature amidoximes 7a, 7b, and
7d were isolated in 92, 93, and 81% yields, respectively, and
had matching spectral data.
9–13.
All of these reactions were conducted under nitrogen
atmosphere. Carboxylic acid (10.5 mmol) was added to a solution
of CDI (1.7 g, 10.5mmol) in acetonitrile (30 ml). Upon the
completion of carbon dioxide evolution, amidoxime 2 (10mmol)
was added to the reaction mixture and the agitation is continued
for 30 min at RT. DBU (3.0 g, 20mmol) was then added, and the
reaction mixture was heated to 60 ꢀC. After 1 h, the mixture was
cooled to RT and diluted with water (30mL). The product was
filtered, washed with 1:1 ACN-water (20 mL) and dried under
vacuum at 50 ꢀC to give oxadiazoles 1, 9–13.
3-(4-Dimethylaminophenyl)-5-(4’-nitrophenyl)-1,2,4-oxadiazole
(9a). 1H NMR (d, Pyridine-d5): 2.82 (s, 6H), 6.84 (d, 2H), 8.26–
8.40 (m, 6H). Anal. Calcd. For C16H14N4O3: C, 61.93; H, 4.55; N,
18.06. Found: C, 62.27; H, 4.16; N, 18.05.
3-(4-Dimethylaminophenyl)-5-(4’-methoxyphenyl)-1,2,4-oxadiazole
(9b). 1H NMR (d, CDCl3): 3.03 (s, 6H), 3.88 (s, 3H), 6.75 (d, 2H),
7.01 (d, 2H), 8.00 (d, 2H), 8.13 (d, 2H). 13C NMR (d, CDCl3): 40.4
(2C), 55.6, 111.4 (2C), 114.1 (2C), 116.9, 128.3 (2C), 129.6 (2C),
151.7 (d), 162.4 (d), 168.3 (d), 174.3. Anal. Calcd. For C17H17N3O2:
C, 69.14; H, 5.80; N, 14.23. Found: C, 69.35; H, 5.51; N, 14.28.
General procedure for the cyclization of acylamidoximes 7a-d
into oxadiazoles 1a, 9a–c.
A solution of acylimidazole 7
(1.0mmol) and DBU (0.30 g, 2.0 mmol) in acetonitrile (3.0 mL) is
heated to 60ꢀC. After 1 h, the mixture is cooled at RT and diluted
with water (3.0mL). The product is filtered, washed with 1:1
ACN-water (1.5 mL) and dried under vacuum at 50 ꢀC to give
oxadiazoles 1a, 9a–c in 94, 91, 89, 92% yields, respectively
(see the aforementioned one-pot procedure for characterization of
these compounds).
REFERENCES AND NOTES
5-(2-Chloro-4-fluorophenyl)-3-(4’-fluorophenyl)-1,2,4-oxadiazole
(10). 1H NMR (d, CDCl3): 7.11–7.23 (m, 3H), 7.32 (m, 1H),
8.10–8.21 (m, 3H). 13C NMR (d, CDCl3): 114.6 (d), 115.8 (d, 2C),
118.7 (d), 119.8, 122.6 (d), 129.3 (d, 2C), 133.3 (d), 135.1 (d),
163.9 (d), 164.1 (d), 167.3, 173.0. Anal. Calcd. For C14H7ClF2
N2O: C, 57.45; H, 2.41; N, 9.57. Found: C, 57.81; H, 2.04; N, 9.48.
[1] a) Luthman, K.; Borg, S.; Hacksell, U. Methods Mol Med
1999, 23, 1; b) For more recent examples see: Farooqui, M.; Bora, R.;
Patil, C. R. European J. Med. Chem. 2009, 44, 794; Wu, Z.; Hartnett,
J. C. PCT Int. Appl. 2009 WO 2009051705; Hobson, A.D.; Fix-Stenzel,
S. R.; Cusack, K. P.; Breinlinger, E. C.; Ansell, G. K.; Stoffel, R. H., Woller,
K. R., Grongsaard, P. US Patent 7,834,039, 2010.
[2] Jochims, J. C. In Comprehensive Heterocyclic Chemistry
II; Stor, R. C., Ed.; Pergamon Press: Oxford, 1996; Vol. 4,
pp 179–228.
5-Benzyl-3-(4-fluorophenyl)-1,2,4-oxadiazole (11). 1H NMR
(d, CDCl3): d 4.27 (s, 2H), 7.14 (t, 2H), 7.26–7.40 (m, 5H), 8.05
(m, 2H). 13C NMR (d, CDCl3): 33.2; 115.7 (d, 2C), 122.7, 127.3,
128.6 (4C), 129.2 (d, 2C), 133.1, 164.0 (d), 167.1, 177.5. Anal.
Calcd. For C15H11F N2O: C, 70.86; H, 4.36; N, 11.02. Found: C,
71.05; H, 4.10; N, 11.03.
[3] Eloy, F.; Lenaers, R. Chem Rev 1962, 62, 155.
[4] a) Chiou S.; Shine, H. J. J Heterocycl Chem 1989, 27, 125; b)
Liang, G.-B.; Feng, D. D. Tetrahedron Lett 1996, 37, 6627; c) Deegan, T.
L.; Nitz, T. J.; Cebzanov, D.; Pufko, D. E.; Porco J. A. Bioorg Med Chem
Lett 1999, 9, 209; d) Poulain, R. F.; Tartar, A. L.; Deprez, B. P. Tetrahe-
dron Lett 2001, 42, 1495; e) Pipik, B.; Ho, G.-J.; Williams, J. M.; Conlon,
D. A. Synth Commun 2004, 34, 1863; f) Wang, Y.; Miller, R. L.; Sauer,
D. R.; Djuric, S. W. Org Lett 2005, 7, 925.
[5] For additional detailes on the oxadiazole formation mechanism
see: Ooi, N. S.; Wilson, D. S. J Chem Soc Perkin Trans 2 1980, 12, 1792.
[6] Lasovsky, J.; Grambal, F. Coll Czech Chem Commun 1985,
50, 2722.
5-(trans-2-Phenylcyclopropyl)-3-(4’-fluorophenyl)-1,2,4-
oxadiazole (13).
1H NMR (d, CDCl3): 1.71 (m, 1H), 1.90
(m, 1H), 2.48 (m, 1H), 2.79 (m, 1H), 7.09–7.19 (m, 4H), 7.19–7.26
(m, 1H), 7.31 (m, 2H), 8.04 (m, 2H). 13C NMR (d, CDCl3): 18. 66
(CH2), 18.78, 28.51, 115.7 (d, 2C), 122.9, 125.9 (2C), 119.8, 126.6,
128.3 (2C), 129.2 (d, 2C), 138.7, 162.7, 165.2, 166.9, 179.7. Anal.
Calcd. For C17H13F N2O: C, 72.85; H, 4.67; N, 9.99. Found: C,
73.25; H, 4.36; N, 9.98.
Previously reported in the literature oxadiazoles 1a, 9c–f, and
12 were isolated in the yields provided in Table 3 and had
matching spectral data.
[7] a) Borg, S.; Estenne-Bouhtou, G.; Luthman, K.; Csoregh, I.;
Hesselink, W.; Hacksell, U. J Org Chem 1995, 60, 3112; b) Amarasinghe, K.
K. D.; Maier, M. B.; Srivastava, A.; Gray, J. L. Tetrahedron Lett 2006, 47, 3629.
[8] Staab, H. A. Angew Chem Int Ed 1962, 1, 351.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet